Table B.1.
Summary of the data extracted from the relevant papers on thermal inactivation parameters of members of the family Parvoviridae
| Virus | Temperature (°C) | D‐value or point estimate of time to 1 log reduction (min) | Matrix | Experimental conditions | Reference |
|---|---|---|---|---|---|
| Bovine parvovirus (BPV) | 60 | 433,0 (a) | Serum albumin |
Suspension medium: plasma. Haden strain, titre: 108 infectious units/mL. Albumin solution. |
Brauniger et al. (2000) |
| 60 | 257,8 (a) | Distilled water |
Suspension medium: AquaDest. Haden strain, titre: 108 infectious units/mL. Albumin solution. |
||
| 55 | 133,3; 576,0 (b) | Viruses on filters within solid carriers | Thermophilic fermentation. Virus (titre: 5.8 log TCID50/mL) adsorbed on filters placed within minced meat. | Paluszak et al. (2010) | |
| 55 | 150,0; 640,0 (b) | Viruses on filters within solid carriers |
Thermophilic fermentation. Virus (titre: 5.8 log TCID50/mL) adsorbed on filters placed within small meat carriers. |
||
| 55 | 600,0; 720,0 (b) | Viruses on filters within solid carriers |
Thermophilic fermentation. Virus (titre: 5.8 log TCID50/mL) adsorbed on filters placed within large meat carriers. |
||
| 55 | 240,0; 720,0 (b) | Viruses on filters within solid carriers |
Thermophilic fermentation. Virus (titre: 5.8 log TCID50/mL) adsorbed on filters placed within bone carriers. |
||
| 55 | 100,0; 443,1 (b) | Culture medium |
Thermophilic fermentation. Viral suspension (titre: 5.8 log TCID50/mL) in tubes. |
||
| 56,4 | 7236,2 (a) | Viruses on filters | Anaerobic thermophilic digestion. Virus (Haden strain) adsorbed on filters (106 PFU/filter). | Spillman et al. (1987) | |
| 60,6 | 3171,8 (a) | Viruses on filters | Aerobic thermophilic digestion. Pressure 15 kPa. Virus (Haden strain) adsorbed on filters (106 PFU/filter). Inactivation rate constant: 0,454 ± 0,018/day | ||
| 70,5 | 2087,0 (a) | Viruses on filters | Pasteurisation. Virus (Haden strain) adsorbed on filters (106 PFU/filter). Inactivation rate constant: 0,69 ± 0,018/day | ||
| Canine parvovirus (CPV) | 60 | 193,5 (b) | Blood and plasma‐derived products | Pasteurisation, albumin concentration 4% | Gröner et al. (2018) |
| 60 | 545,5 (b) | Blood and plasma‐derived products | Pasteurisation. Stabilised intermediates in plasma manufacturing processes (standard conditions). | ||
| 60 | 400,0b | Blood and plasma‐derived products | Pasteurisation. Stabilised intermediates in plasma manufacturing processes (stabiliser concentration increased to 110%). | ||
| 58 | 517,2 (b) | Blood and plasma‐derived products | Pasteurisation. Stabilised intermediates in plasma manufacturing processes (temperature reduced to 58°C). | ||
| Minute virus of mice (MVM) | 90 | 0,1; 0,2 (b) | Glucose concentrate solution | HTST pasteurisation in 50% glucose solution. Viral titre: 107 TCID50/mL | Gemmell et al. (2021) |
| Porcine parvovirus (PPV) | 60 | 73,7 (a) | Blood and plasma‐derived products | Pasteurisation. NADL‐2 strain, titre: 108 TCID50/mL | Blumel et al. (2002) |
| 52 | 1006,2 (a) | Faecal suspension | Strain 893/76, titre: 107,2 TCID50/g | Elving et al. (2014) | |
| 55 | 1336,8 (a) | Saline solution | Strain 893/76, titre: 107,2 TCID50/mL | ||
| 70 | 74,2 (a) | Saline solution | Strain 893/76, titre: 107,2 TCID50/mL | ||
| 60 | 24,7 (a) | Blood and plasma‐derived products | Pasteurisation. Viral titre: 4.88 log TCID50/mLl | Huangfu et al. (2017) |
D value.
Point estimates of time to 1 log reduction.